tm logo
SAIL BIOMEDICINES
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 30 Oct 2024

Last Applicant/ Owned by

101 South St., Suite 400

Somerville

MA

02143

Serial Number

98297795 filed on 04th Dec 2023

Registration Number

N/A

Correspondent Address

Christina M. Licursi

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

Boston, MA 02210-2206

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SAIL BIOMEDICINES

Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; research and development in the field of computational biology, biotechnology and pharmaceuticals Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic disease Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; research and development in the field of computational biology, biotechnology and pharmaceuticals


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders; Therapeutic preparations to modulate metabolism; pharmaceutical preparations and agents to modulate metabolism; pharmaceutical agents that modulate metabolism for scientific and research use; therapeutic pharmaceuticals for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; pharmaceutical preparations for the treatment of disease, namely, autoimmune diseases and disorders, bone and joint diseases and disorders, cancer, cardiovascular diseases and disorders, gastro-intestinal diseases and disorders, hematologic diseases and disorders, infectious diseases, kidney diseases and disorders, lung diseases and disorders, metabolic diseases and disorders, muscle diseases and disorders, nephrology diseases and disorders, neurodegenerative diseases and disorders, neurologic diseases and disorders, ophthalmic disease and disorders, skin diseases and disorders; therapeutic pharmaceuticals for modulating metabolism


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98297795

Mark Type

No Service/Collective Mark

Attorney Docket Number

No V03392000400

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
24th Oct 2024APPROVED FOR PUB - PRINCIPAL REGISTER
25th Sep 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
25th Sep 2024TEAS/EMAIL CORRESPONDENCE ENTERED
25th Sep 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
02th Jul 2024ASSIGNED TO EXAMINER
02th Jul 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
02th Jul 2024NON-FINAL ACTION E-MAILED
02th Jul 2024NON-FINAL ACTION WRITTEN
28th Feb 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04th Dec 2023NEW APPLICATION ENTERED